Association of Serum Fibroblast Growth Factor 23 Levels with the Presence and Severity of Hepatic Steatosis Is Independent of Sleep Duration in Patients with Diabetes

PURPOSE: Fibroblast growth factor (FGF) 23 is currently recognized to be involved in the occurrence and development of metabolic diseases. The present study aimed to investigate the association between serum FGF23 levels and hepatic steatosis, as well as the influence of sleep duration. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiang, Yang, Lijuan, Yu, Weihui, Pan, Wei, Chen, Xueqin, Li, Qianqian, Zhou, Jingzong, Gu, Xuejiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174196/
https://www.ncbi.nlm.nih.gov/pubmed/32368110
http://dx.doi.org/10.2147/DMSO.S241348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174196/
https://www.ncbi.nlm.nih.gov/pubmed/32368110
http://dx.doi.org/10.2147/DMSO.S241348

Ejemplares similares